ACB vs VEON

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 22, 2026

ACB

33.4
AI Score
VS
VEON Wins

VEON

40.7
AI Score

Investment Advisor Scores

ACB

33score
Recommendation
EXTENDED

VEON

41score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric ACB VEON Winner
Forward P/E 109.8901 8.4317 VEON
PEG Ratio 0 2.2274 Tie
Revenue Growth -8.8% 16.9% VEON
Earnings Growth -94.7% -78.9% VEON
Tradestie Score 33.4/100 40.7/100 VEON
Profit Margin -38.2% 1.2% VEON
Beta 1.00 1.00 Tie
AI Recommendation EXTENDED HOLD Tie

Relative Price Performance (Last 90 Days)

ACB 1M: +46.5% · 3M: +10.7% VEON 1M: +14.2% · 3M: +4.7%

Current Technical Phase

ACB

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 73

RSI (14): 73.2 · Price: $3.94

VEON

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (0.7% over 20 days), RSI 70

RSI (14): 69.9 · Price: $59.38

Fundamentals Snapshot

Metric ACB VEON
Market Cap
Forward P/E -656.7 7.2
Trailing P/E 56.4
Revenue (TTM)
Revenue Growth -0.1% 0.2%
Gross Margin 0.4% 0.9%
Operating Margin -0.1% 0.3%
EPS -0.65 1.00
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, VEON is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.